JENNIFER WIEGAND: Open Payments
NPI 1548444573 · CLERMONT, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 14 payments from 4 companies in 2025. Trend: 2023 $128 · 2024 $57 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $209 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $14 |
Products named: CAPLYTA, AIRSUPRA, VOQUEZNA, MOUNJARO.
Industry payments across GA — which companies pay providers there.
